Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORION-4: Inclisiran in Atherosclerotic Cardiovascular Disease
NCT03705234Phase 3Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Oct 2018
- Primary completion
- Oct 2026
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 2
01
Overview
A Phase 3 trial of inclisiran in atherosclerotic cardiovascular disease (ASCVD), sponsored by University of Oxford. Started Oct 2018; status: active, not recruiting.
02
Drugs
inclisiran
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT03705234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705234.